{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:56:48Z","timestamp":1777561008616,"version":"3.51.4"},"reference-count":28,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7572","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T06:54:46Z","timestamp":1557471286000},"source":"Crossref","is-referenced-by-count":6,"title":["Optimal ratio of 18\u03b1\u2011 and 18\u03b2\u2011glycyrrhizic acid for preventing alcoholic hepatitis in rats"],"prefix":"10.3892","author":[{"given":"Xiaowei","family":"Huo","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, Hebei 071002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoke","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, Hebei 071002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zepeng","family":"Cao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, Hebei 071002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzhe","family":"Qiao","sequence":"additional","affiliation":[{"name":"Oncology Department, Hebei Yiling Hospital, Shijiazhuang, Hebei 050091, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, Hebei 071002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangbo","family":"Meng","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, Hebei 071002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, Hebei 071002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"key20200713100130_b1-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/09595230600944438","article-title":"Global use of alcohol, drugs and tobacco","volume":"25","author":"Anderson","year":"2006","journal-title":"Drug Alcohol Rev"},{"key":"key20200713100130_b2-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/hep.29242","article-title":"Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational study","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"key20200713100130_b3-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"G516","DOI":"10.1152\/ajpgi.00537.2010","article-title":"Innate immunity in alcoholic liver disease","volume":"300","author":"Gao","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20200713100130_b4-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1530-0277.2010.01399.x","article-title":"Molecular mechanisms of alcoholic liver disease: Innate immunity and cytokines","volume":"35","author":"Miller","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"key20200713100130_b5-etm-0-0-7572","first-page":"185","article-title":"Impact of alcohol abuse on the adaptive immune system","volume":"37","author":"Pasala","year":"2015","journal-title":"Alcohol Res"},{"key":"key20200713100130_b6-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"key20200713100130_b7-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","article-title":"Increased plasma tumor necrosis factor in severe alcohol hepatitis","volume":"112","author":"Bird","year":"1990","journal-title":"Ann Intern Med"},{"key":"key20200713100130_b8-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2249.2012.04609.x","article-title":"Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates","volume":"169","author":"Degr\u00e9","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"key20200713100130_b9-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1111\/acer.12558","article-title":"Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines","volume":"38","author":"Rachakonda","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"key20200713100130_b10-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1034\/j.1600-0676.2001.021004280.x","article-title":"Chinese medicinal herbs for chronic hepatitis B: A systematic review","volume":"21","author":"Liu","year":"2001","journal-title":"Liver"},{"key":"key20200713100130_b11-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5511\/plantbiotechnology.26.101","article-title":"Economic importance of licorice","volume":"26","author":"Hayashi","year":"2009","journal-title":"Plant Biotechnol"},{"key":"key20200713100130_b12-etm-0-0-7572","first-page":"415","article-title":"Therapeutic effects of glycyrrhizic acid","volume":"8","author":"Ming","year":"2013","journal-title":"Nat Prod Commun"},{"key":"key20200713100130_b13-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.3748\/wjg.v19.i24.3781","article-title":"Glycyrrhizic acid attenuates CCl4-induced hepatocyte apoptosis in rats via a p53-mediated pathway","volume":"19","author":"Guo","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20200713100130_b14-etm-0-0-7572","first-page":"872139","article-title":"Glycyrrhizic acid in the treatment of liver diseases: Literature review","volume":"2014","author":"Li","year":"2014","journal-title":"Biomed Res Int"},{"key":"key20200713100130_b15-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1189\/jlb.0112038","article-title":"Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4\/MD-2 complex signaling in a different manner","volume":"91","author":"Honda","year":"2012","journal-title":"J Leukoc Biol"},{"key":"key20200713100130_b16-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tox.2017.05.012","article-title":"Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption","volume":"386","author":"Wang","year":"2017","journal-title":"Toxicology"},{"key":"key20200713100130_b17-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1055\/s-0033-1349837","article-title":"Comparison of the exposure of glycyrrhizin and its metabolites and the pseudoaldosteronism after intravenous administration of alpha- and beta-glycyrrhizin in rat","volume":"63","author":"Xu","year":"2013","journal-title":"Drug Res (Stuttg)"},{"key":"key20200713100130_b18-etm-0-0-7572","first-page":"247","article-title":"Analysis of content differences and variation trends of the principal component isomers and related substances in the four generations of glycyrrhizin preparations","volume":"34","author":"Zhao","year":"2014","journal-title":"Chin J Pharma Anal"},{"key":"key20200713100130_b19-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pharmthera.2017.06.007","article-title":"Targeting inflammation for the treatment of alcoholic liver disease","volume":"180","author":"Xu","year":"2017","journal-title":"Pharmacol Ther"},{"key":"key20200713100130_b20-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4254\/wjh.v9.i12.567","article-title":"Emerging concepts in alcoholic hepatitis","volume":"9","author":"Fung","year":"2017","journal-title":"World J Hepatol"},{"key":"key20200713100130_b21-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"key20200713100130_b22-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"key20200713100130_b23-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.4049\/jimmunol.171.6.3233","article-title":"Crucial role of IL-4\/STAT6 in T cell-mediated hepatitis: Up-regulating eotaxins and IL-5 and recruiting leukocytes","volume":"171","author":"Jaruga","year":"2003","journal-title":"J Immunol"},{"key":"key20200713100130_b24-etm-0-0-7572","first-page":"547","article-title":"Increased plasma interleukin-6 concentrations in alcoholic hepatitis","volume":"119","author":"Hill","year":"1992","journal-title":"J Lab Clin Med"},{"key":"key20200713100130_b25-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/0270-9139(95)90643-6","article-title":"Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease","volume":"22","author":"Kamimura","year":"1995","journal-title":"Hepatology"},{"key":"key20200713100130_b26-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.24599","article-title":"An essential role for MCP-1 in alcoholic liver injury: Regulation of pro-inflammatory cytokines and hepatic steatosis","volume":"54","author":"Mandrekar","year":"2011","journal-title":"Hepatology"},{"key":"key20200713100130_b27-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"7215","DOI":"10.4049\/jimmunol.179.11.7215","article-title":"Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway","volume":"179","author":"El Kasmi","year":"2007","journal-title":"J Immunol"},{"key":"key20200713100130_b28-etm-0-0-7572","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1189\/JLB.0309135","article-title":"Liver natural killer and natural killer T cells: Immunobiology and emerging roles in liver diseases","volume":"86","author":"Gao","year":"2009","journal-title":"J Leukoc Biol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:01:37Z","timestamp":1594630897000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":28,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7572","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]}}}